Gonococcal antimicrobial susceptibility surveillance in the European Union/European Economic Area, 2019
The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC). The quality-assured data produced can be used to inform treatment guidelines.
HIV Continuum of care: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2020 progress report)
In 2020, using data from countries able to provide at least two consecutive stages of the continuum, the overall performance of the European and Central Asian region against the global 90-90-90 targets is 82% of all PLHIV with HIV diagnosed, 67% of those diagnosed with HIV on treatment and 90% of those on treatment virally suppressed. More progress is needed to meet the substantive target of 73% of all PLHIV being virally suppressed, with performance for the overall region at 50% (based on the countries that submitted data for all four stages of the continuum).
Hepatitis B - Annual Epidemiological Report for 2019
For 2019, 30 EU/EEA Member States reported 29 996 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 29 518, corresponds to a crude rate of 7.4 cases per 100 000 population.
Hepatitis C - Annual Epidemiological Report for 2019
In 2019, 37 733 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases leaves 37 660 cases, which corresponds to a crude rate of 8.9 cases per 100 000 population.
Communicable disease threats report, 4-10 July 2021, week 27
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 July 2021 and includes updates on the Olympic games of Tokyo 2020, COVID-19, West Nile virus, measles, dengue, the UEFA European Football Championship 2020, and swine influenza.
HIV Platform tool
The ECDC HIV Platform Tool is a new end-user application that uses statistical and mathematical methods to calculate adjusted estimates from HIV surveillance data, considering the issues of missing data and reporting delay and employing modelling techniques.
The sustainable development goals and hepatitis B and C in the EU/EEA
In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.
Hepatitis B and C testing in the EU/EEA: progress in reaching the elimination targets
This brief will present a snapshot of hepatitis B and C testing in the European Union/European Economic Area (EU/EEA), discussing progress made towards the European action plan 2020 testing target, focussing on key populations and settings for testing, barriers to testing, and testing policies.
Country case studies: ECDC operational guidance on Pre-Exposure Prophylaxis (PrEP) in the EU/EEA and the UK
Supplementary document with country case studies in relation to the ECDC operational guidance on HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: Implementation, standards and monitoring.